Search research articles
Contact Us
Filters
Showing results (161-170 of 217) with videos related to
Page
of 22
Sort By:
Cancer Science
|
October 13, 2012
Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer
Eun Mi Lee, Yong Sang Hong, Kyu-Pyo Kim, et al.
The Journal of Biological Chemistry
|
May 26, 2012
Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF)
Seung-Woo Hong, Dong-Hoon Jin, Jae-Sik Shin, et al.
The British Journal of Surgery
|
August 11, 2021
Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival
Woohyung Lee, Minyoung Oh, Jae Seung Kim, et al.
Journal of Cancer Research and Clinical Oncology
|
March 27, 2023
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma
Yoon Jung Jang, Eo Jin Kim, Hyung-Don Kim, et al.
Targeted Oncology
|
December 28, 2025
Claudin-18.2 and Trop-2 as Emerging Biomarkers in Biliary Tract Cancers: Expression Analysis and Therapeutic Potential
Yeokyeong Shin, Jinho Shin, Hyehyun Jeong, et al.
Journal of Hepatology
|
July 5, 2026
Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study
Do-Youn Oh, Masafumi Ikeda, Teresa Macarulla, et al.
Annals of Surgical Oncology
|
August 15, 2015
Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy
Jeong Eun Kim, Yong Sang Hong, Hwa Jung Kim, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 2017
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
Bum Jun Kim, Jaewon Hyung, Changhoon Yoo, et al.
Cancer Research and Treatment
|
February 6, 2020
Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
Junho Kang, Jae Ho Jeong, Hee-Sang Hwang, et al.
Oncology
|
October 25, 2014
TFAP2E methylation status and prognosis of patients with radically resected colorectal cancer
Seong Joon Park, Seung-mi Kim, Yong Sang Hong, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 217) with videos related to
Sort By:
Page
of 22
Cancer Science
|
October 13, 2012
Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer
Eun Mi Lee, Yong Sang Hong, Kyu-Pyo Kim, et al.
The Journal of Biological Chemistry
|
May 26, 2012
Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF)
Seung-Woo Hong, Dong-Hoon Jin, Jae-Sik Shin, et al.
The British Journal of Surgery
|
August 11, 2021
Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival
Woohyung Lee, Minyoung Oh, Jae Seung Kim, et al.
Journal of Cancer Research and Clinical Oncology
|
March 27, 2023
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma
Yoon Jung Jang, Eo Jin Kim, Hyung-Don Kim, et al.
Targeted Oncology
|
December 28, 2025
Claudin-18.2 and Trop-2 as Emerging Biomarkers in Biliary Tract Cancers: Expression Analysis and Therapeutic Potential
Yeokyeong Shin, Jinho Shin, Hyehyun Jeong, et al.
Journal of Hepatology
|
July 5, 2026
Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study
Do-Youn Oh, Masafumi Ikeda, Teresa Macarulla, et al.
Annals of Surgical Oncology
|
August 15, 2015
Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy
Jeong Eun Kim, Yong Sang Hong, Hwa Jung Kim, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 2017
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
Bum Jun Kim, Jaewon Hyung, Changhoon Yoo, et al.
Cancer Research and Treatment
|
February 6, 2020
Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
Junho Kang, Jae Ho Jeong, Hee-Sang Hwang, et al.
Oncology
|
October 25, 2014
TFAP2E methylation status and prognosis of patients with radically resected colorectal cancer
Seong Joon Park, Seung-mi Kim, Yong Sang Hong, et al.
Page
of 22